Last reviewed · How we verify
NCT06093074: SMS_trauma
Self-management Program for Patients in the Sub-acute Phase After Traumatic Injury - a Feasibility Study
NA trial testing self-management program after traumatic injuries in Self-management in 11 participants. Completed in 27 May 2024.
20 February 2024
Quick facts
| Lead sponsor | Oslo University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 11 |
| Start date | 16 October 2023 |
| Primary completion | 20 February 2024 |
| Estimated completion | 27 May 2024 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- self-management program after traumatic injuries
Conditions studied
- Self-management — all drugs for Self-management →
- Feasibility Studies — all drugs for Feasibility Studies →
- Spinal Cord Injuries — all drugs for Spinal Cord Injuries →
- Brain Injuries — all drugs for Brain Injuries →
Sponsor
Oslo University Hospital
Who can join
Adults 18 to 72, any sex, with Self-management or Feasibility Studies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this descriptive non-randomized feasibility study is to assess aspects of feasibility of the intervention arm in a planned full-scale randomized controlled trial testing the effectiveness of a self-management program for persons who have sustained a moderate to severe traumatic injury. All outcomes will be evaluated based on pre-defined success criteria. The main outcomes in the feasibility study are: * Consent rate of eligible patients * Drop-out rate * Attendance rate in the program sessions Secondary outcomes are the participants' acceptance, reception, and perceived usefulness. Other outcomes are fidelity and protocol adherence, as well as the feasibility of a telehealth version of the program and the data collection methods. The participants will receive a group-based self-management program consisting of eight weekly 2.5-hour sessions delivered by a multidisciplinary team. The self-management program is manualized and includes psychoeducation, training in self-management skills and strategies, setting goals, action planning, and sharing of experiences. The participants will also complete the pre- and post-intervention assessments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06093074
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Self-management
Currently open trials in the same condition.
- NCT06826703 — The Effect of Motivational Interviewing on Diabetes Self-Management and Severity of Cyberchondria in Individuals With Di · NA · recruiting
- NCT06850961 — A Digital Health Intervention to Promote Self-management in Patients With Chronic Obstructive Pulmonary Disease · NA · recruiting
- NCT06599840 — Feasibility Study of a Behavioral Parent Intervention to Support Self-management in Pediatric Typ 1 Diabetes · NA · active not recruiting
- NCT04353739 — Testing a Self-management Intervention in HIV+ Asian Pacific Americans · NA · recruiting
Other Oslo University Hospital trials
Trials by the same sponsor.
- NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
- NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
- NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
- NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
- NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06093074 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
- Last refreshed: 30 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06093074.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing